Who Supplies Bortezomib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Bortezomib exports, with 200+ registered manufacturers shipping to buyers across 109+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 18.4% (export value: $4.0M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (9.8%, $2.1M). MSN LABORATORIES PRIVATE LIMITED (7.8%, $1.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Bortezomib? Top Manufacturers & Their Buyers
Flow of Bortezomib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Bortezomib Supplier Network — Key Market Intelligence
The Bortezomib export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 18.4% share, shipping $4.0M worth of product across 57 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $2.1M (9.8%) to the overall market. Combined, the top two suppliers alone account for 28.2% of all Bortezomib exports, indicating a relatively concentrated supply base.
Across all 200 tracked manufacturers, the total Bortezomib export value stands at $21.9M from 1.4K shipments. The market average shipment value is $15.8K. The single largest buyer relationship in terms of trade value is SUN FARMACUTICA DO BRASIL LIMITEDA, receiving $1.5M worth of product.
The combined buyer network spans 24 named purchasing companies, including SUN FARMACUTICA DO BRASIL LIMITEDA, SUN FARMACEUTICA DO BRASIL LTDA, YUSEN LOGISTICS BENELUX BELGIUM, M/S. SUN FARMACEUTICA DO BRAZIL LTD, EUGIA US LLC, and 19 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Bortezomib exporter from India, with a market share of 18.4% and a total export value of $4.0M across 57 shipments. Their average shipment value of $70.6K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUN FARMACUTICA DO BRASIL LIMITEDA — $1.5M across 21 shipments (37.1% of this supplier's total exports)
• SUN FARMACUTICA DO BRASIL LIMITEDA — $1.0M across 14 shipments (25.4% of this supplier's total exports)
• SUN FARMACEUTICA DO BRASIL LTDA — $584.3K across 8 shipments (14.5% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $539.8K across 8 shipments (13.4% of this supplier's total exports)
• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $385.4K across 5 shipments (9.6% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $70.6K is 347% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Bortezomib exporter from India, with a market share of 9.8% and a total export value of $2.1M across 69 shipments. Their average shipment value of $30.9K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. EUGIA US LLC, is the dominant customer, accounting for 63.2% of this supplier's tracked business. Top customers include:
• EUGIA US LLC, — $1.3M across 44 shipments (63.2% of this supplier's total exports)
• EUGIA US LLC, — $574.6K across 19 shipments (26.9% of this supplier's total exports)
• SYNERRV SDN BHD — $73.0K across 2 shipments (3.4% of this supplier's total exports)
• MILPHARM LIMITED — $72.1K across 2 shipments (3.4% of this supplier's total exports)
• EUGIA PHARMA MALTA L — $66.6K across 2 shipments (3.1% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $30.9K is 96% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
3MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the third-largest Bortezomib exporter from India, with a market share of 7.8% and a total export value of $1.7M across 97 shipments. Their average shipment value of $17.6K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $489.0K across 28 shipments (28.7% of this supplier's total exports)
• MEDISON PHARMA — $440.7K across 25 shipments (25.9% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC — $342.3K across 19 shipments (20.1% of this supplier's total exports)
• AMERICAN HEALTH PACK — $216.7K across 12 shipments (12.7% of this supplier's total exports)
• NOVADOZ PHARMACEUTIC — $215.5K across 12 shipments (12.6% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $17.6K is 11% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
4DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the fourth-largest Bortezomib exporter from India, with a market share of 3.0% and a total export value of $662.7K across 10 shipments. Their average shipment value of $66.3K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR REDDY S LABORATOR — $240.8K across 4 shipments (36.3% of this supplier's total exports)
• DR REDDYS FARMACEUTI — $211.7K across 3 shipments (31.9% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $88.9K across 1 shipments (13.4% of this supplier's total exports)
• DR REDDYS FARMACEUTI — $62.7K across 1 shipments (9.5% of this supplier's total exports)
• Reddys Pharma Iberia — $58.6K across 1 shipments (8.8% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $66.3K is 319% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
5FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the fifth-largest Bortezomib exporter from India, with a market share of 3.0% and a total export value of $649.9K across 99 shipments. Their average shipment value of $6.6K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 79.2% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $514.9K across 78 shipments (79.2% of this supplier's total exports)
• FRESENIUS KABI CHILE — $49.4K across 8 shipments (7.6% of this supplier's total exports)
• FRESENIUS KABI DEUTSCHLAND GMBH — $49.0K across 7 shipments (7.5% of this supplier's total exports)
• FRESENIUS KABI CHILE — $19.9K across 3 shipments (3.1% of this supplier's total exports)
• BIO TECH PHARMA S.A — $16.7K across 3 shipments (2.6% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (99 shipments) at a per-shipment value of $6.6K, indicating a broad distribution network with many smaller, regular orders.
6VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Bortezomib exporter from India, with a market share of 2.3% and a total export value of $509.3K across 44 shipments. Their average shipment value of $11.6K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• P T — $159.2K across 14 shipments (31.3% of this supplier's total exports)
• E P H K — $117.3K across 10 shipments (23.0% of this supplier's total exports)
• V P G — $113.0K across 10 shipments (22.2% of this supplier's total exports)
• P P — $76.9K across 7 shipments (15.1% of this supplier's total exports)
• TO THE ORDER OF: — $42.9K across 4 shipments (8.4% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (44 shipments) at a per-shipment value of $11.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Bortezomib Flows
Once Bortezomib leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $21.9M. Brazil absorbs the largest share at 28.3% ($6.2M), followed by United States (25.4%) and Israel (5.1%).
In Brazil — the top destination — named importers include SUN FARMACUTICA DO BRASIL LTDA, SUN FARMACUTICA DO BRASIL LIMITEDA, SUN FARMACEUTICA DO BRAZIL LTDA.. In United States, key buyers are EUGIA US LLC,, EUGIA US LLC, AUROLOGISTICS LLC (AUROMEDICS PHARM.
This geographic spread reflects Bortezomib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Bortezomib Go? Top Importing Countries & Their Buyers
Trade flow of Bortezomib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Bortezomib imports from India, with a total trade value of $6.2M across 23 shipments — representing a 28.3% share of all Bortezomib exports. The average shipment value of $268.8K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.
Named Bortezomib importers in Brazil: SUN FARMACUTICA DO BRASIL LTDA is the largest buyer, accounting for 18.6% ($1.1M) of this market's total imports.
• SUN FARMACUTICA DO BRASIL LTDA — $1.1M (18.6% of Brazil's total)
• SUN FARMACUTICA DO BRASIL LIMITEDA — $1.0M (16.5% of Brazil's total)
• SUN FARMACEUTICA DO BRAZIL LTDA. — $584.3K (9.5% of Brazil's total)
Key Insight: Brazil's per-shipment average of $268.8K (1600% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Bortezomib imports from India.
2United States
United States ranks as the second-largest destination for Bortezomib imports from India, with a total trade value of $5.6M across 35 shipments — representing a 25.4% share of all Bortezomib exports. The average shipment value of $158.7K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Bortezomib importers in United States: EUGIA US LLC, is the largest buyer, accounting for 24.3% ($1.3M) of this market's total imports.
• EUGIA US LLC, — $1.3M (24.3% of United States's total)
• EUGIA US LLC — $987.9K (17.8% of United States's total)
• AUROLOGISTICS LLC (AUROMEDICS PHARM — $849.3K (15.3% of United States's total)
Key Insight: United States's per-shipment average of $158.7K (904% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Bortezomib imports from India.
3Israel
Israel ranks as the third-largest destination for Bortezomib imports from India, with a total trade value of $1.1M across 6 shipments — representing a 5.1% share of all Bortezomib exports. The average shipment value of $186.0K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bortezomib importers in Israel: MEDISON PHARMA is the largest buyer, accounting for 39.5% ($440.7K) of this market's total imports.
• MEDISON PHARMA — $440.7K (39.5% of Israel's total)
Key Insight: Israel's per-shipment average of $186.0K (1077% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Israel is a key market for Bortezomib imports from India.
4Belgium
Belgium ranks as the fourth-largest destination for Bortezomib imports from India, with a total trade value of $871.4K across 20 shipments — representing a 4.0% share of all Bortezomib exports. The average shipment value of $43.6K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bortezomib importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 100.0% ($871.4K) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $871.4K (100.0% of Belgium's total)
Key Insight: Belgium's per-shipment average of $43.6K (176% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Bortezomib imports from India.
5Germany
Germany ranks as the fifth-largest destination for Bortezomib imports from India, with a total trade value of $821.9K across 66 shipments — representing a 3.8% share of all Bortezomib exports. The average shipment value of $12.5K is below the global average of $15.8K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Bortezomib importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 74.2% ($609.5K) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $609.5K (74.2% of Germany's total)
Key Insight: Germany receives frequent, smaller shipments of Bortezomib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Germany is a key market for Bortezomib imports from India.
People Also Ask — Bortezomib Supplier & Trade Network
Who are the top suppliers of Bortezomib from India?+
Which companies buy Bortezomib from Indian manufacturers?+
Where does Bortezomib exported from India go?+
What is the market share of the top Bortezomib supplier from India?+
What is the average shipment value for Bortezomib exports from India?+
Is Bortezomib manufactured in India and exported globally?+
Which country imports the most Bortezomib from India?+
Who are the buyers of Bortezomib in United States?+
How concentrated is the Bortezomib supplier market in India?+
How do I find verified buyers for Bortezomib in specific countries?+
Bortezomib Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Bortezomib exporter with a 18.4% market share and $4.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 200 suppliers collectively account for 44.3% of all tracked Bortezomib exports, with a combined trade value of $21.9M.
- 3Brazil is the largest destination market, absorbing 28.3% of India's Bortezomib exports ($6.2M). United States (25.4%) and Israel (5.1%) follow.
- 4With 1.4K total shipments averaging $15.8K each, the Bortezomib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include SUN FARMACUTICA DO BRASIL LIMITEDA, SUN FARMACUTICA DO BRASIL LIMITEDA, EUGIA US LLC,, EUGIA US LLC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 109 countries
Network value: $21.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bortezomib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Bortezomib.
- 2.Flow Mapping: 200 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,383 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 109 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,383 Verified Shipments
200 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists